Anne Altmeyer's most recent trade in Corbus Pharmaceuticals Holdings Inc was a trade of 16,000 Stock options (right to buy) done . Disclosure was reported to the exchange on May 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Corbus Pharmaceuticals Hol... | Anne Altmeyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2025 | 16,000 | 16,000 | - | - | Stock options (right to buy) | |
| Corbus Pharmaceuticals Hol... | Anne Altmeyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2025 | 4,800 | 6,191 (0%) | 0% | 0 | Common Stock, par value $0.0001 per share | |
| Corbus Pharmaceuticals Hol... | Anne Altmeyer | Director | Sale of securities on an exchange or to another person at price $ 7.25 per share. | 30 May 2025 | 1,392 | 1,391 (0%) | 0% | 7.3 | 10,096 | Common Stock, par value $0.0001 per share |
| Corbus Pharmaceuticals Hol... | Anne Altmeyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 2,783 | 2,783 (0%) | 0% | 0 | Common Stock, par value $0.0001 per share | |
| Corbus Pharmaceuticals Hol... | Anne Altmeyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 2,783 | 2,783 | - | - | Stock Option (right to buy) | |
| Corbus Pharmaceuticals Hol... | Anne Altmeyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 5,300 | 5,300 | - | - | Stock Option (right to buy) | |
| Corbus Pharmaceuticals Hol... | Anne Altmeyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Sep 2022 | 159,200 | 159,200 | - | - | Stock Option(right to buy) |